{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:04:53Z","timestamp":1778850293068,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.contraception.2010.02.024","type":"journal-article","created":{"date-parts":[[2010,4,14]],"date-time":"2010-04-14T08:26:12Z","timestamp":1271233572000},"page":"296-300","source":"Crossref","is-referenced-by-count":1,"title":["Reduced community access to a key contraceptive: public health consequence from false suspicion of HIV-contaminated injectables"],"prefix":"10.1016","volume":"82","author":[{"given":"David W.","family":"Jenkins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Krysiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Sexton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2010.02.024_bib1","first-page":"4","article-title":"Govt withdraws suspicious contraceptive","volume":"1","author":"Chanda","year":"2008","journal-title":"The Post (Zambia)"},{"key":"10.1016\/j.contraception.2010.02.024_bib2","first-page":"4","article-title":"Failure to intercept Depo Provera upon importation disappoints ZMA","volume":"1","author":"Sichalwe","year":"2008","journal-title":"The Post (Zambia)"},{"key":"10.1016\/j.contraception.2010.02.024_bib3","first-page":"2","article-title":"State withdraws Depo Provera contraceptive","volume":"1","author":"Mwitwa","year":"2008","journal-title":"Zambia Daily Mail"},{"key":"10.1016\/j.contraception.2010.02.024_bib4","series-title":"Zambia: Depo Provera Does Not Contain HIV \u2014 Chituwo, Feb 2, 2008","year":"2008"},{"key":"10.1016\/j.contraception.2010.02.024_bib5","unstructured":"The procedure used to quantify medroxyprogesterone acetate in DMPA was based on a proprietary manufacturer method. An alternative method is the Assay procedure found in the USP monograph for Medroxyprogesterone Acetate Injectable Suspension."},{"key":"10.1016\/j.contraception.2010.02.024_bib6","unstructured":"USP <791> pH."},{"key":"10.1016\/j.contraception.2010.02.024_bib7","series-title":"Amplicor\u00ae HIV-1 Monitor RNA Test, Version 1.5","year":"2001"},{"key":"10.1016\/j.contraception.2010.02.024_bib8","series-title":"Amplicor\u00ae HIV-1 DNA Test, Version 1.5","year":"2001"},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib9.1","unstructured":"(a) Immunotek Quantitative Human IgG ELISA [package insert]. Buffalo (NY): ZeptoMetrix Corporation; 2007."},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib9.2","unstructured":"(b) Immunotek Quantitative Human IgG ELISA [Internet site]. Buffalo: Zeptometrix Corporation. Available from: http:\/\/www.zeptometrix.com\/0801182.pdf [Accessed October 9, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib10","series-title":"Genie II HIV-1\/HIV-2","year":"2000"},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib11.1","unstructured":"(a) Determine\u2122 HIV-1\/2 [package insert]. Bedford (UK): Inverness Medical; 2007."},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib11.2","unstructured":"(b) Determine\u2122 HIV-1\/2 [Internet site]. Bedford: Inverness Medical. Available from: http:\/\/www.determinetest.com\/pdf\/PI%20HIV%20CE%20467870R1.pdf [Accessed October 9, 2009]."},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib12.1","unstructured":"(a) Uni-Gold\u2122 Recombigen\u00ae HIV [package insert]. Co. Wicklow (Ireland): Trinity Biotech; 2004."},{"key":"#cr-split#-10.1016\/j.contraception.2010.02.024_bib12.2","unstructured":"(b) Uni-Gold\u2122 Recombigen\u00ae HIV [Internet site]. Wicklow: Trinity Biotech. Available from: http:\/\/www.unigoldhiv.com\/package_insert.pdf [Accessed October 9, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib13","unstructured":"Medroxyprogesterone Injection \u2014 Official FDA Information, Side Effects and Uses [Internet site]. Auckland (New Zealand): Drugsite Trust. Available from: http:\/\/www.drugs.com\/pro\/medroxyprogesterone-injection.html [Accessed on February 5, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib14","unstructured":"Demographic and Health Surveys. Zambia 2007 Final Report [Internet site]. Calverton (MD): Measure DHS. Available from: http:\/\/www.measuredhs.com\/pubs\/pub_details.cfm?ID=894&ctry_id=47&SrchTp=ctry&flag=sur&cn=Zambia [Accessed on September 3, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib15","unstructured":"United Nations, Dept. of Economic and Socials Affairs, Population Division. World Contraceptive Use 2007. [Internet site]. Geneva: United Nations. Available from: http:\/\/www.un.org\/esa\/population\/publications\/contraceptive2007\/contraceptive2007.htm [Accessed on September 3, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib16","series-title":"Contraceptive Technology","article-title":"Contraceptive efficacy","author":"Trussell","year":"2007"},{"issue":"2","key":"10.1016\/j.contraception.2010.02.024_bib17","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1371\/journal.pmed.0050032","article-title":"A collaborative epidemiological investigation into the criminal fake artesunate trade in South East Asia","volume":"5","author":"Newton","year":"2008","journal-title":"PLoS Med."},{"issue":"7030","key":"10.1016\/j.contraception.2010.02.024_bib18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/434132a","article-title":"Counterfeit pharmaceuticals: murder by medicine","volume":"434","author":"Aldhous","year":"2005","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.contraception.2010.02.024_bib19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/02724936.1992.11747577","article-title":"Diethylene glycol poisoning in Nigerian children","volume":"12","author":"Okuonghae","year":"1992","journal-title":"Ann Trop Paediatr"},{"issue":"30","key":"10.1016\/j.contraception.2010.02.024_bib20","first-page":"649","article-title":"Fatalities associated with ingestion of diethylene glycol-contaminated glycerin used to manufacture acetaminophen syrup\u2014Haiti, November 1995\u2013June 1996","volume":"45","author":"Centers for Disease Control and Prevention (CDC)","year":"1996","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2010.02.024_bib21","series-title":"CDC Helps Solve Panama Mystery Illness","author":"Centers for Disease Control and Prevention News","year":"2006"},{"issue":"6","key":"10.1016\/j.contraception.2010.02.024_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/jat\/31.6.295","article-title":"Identification and quantification of diethylene glycol in pharmaceuticals implicated in poisoning epidemics: an historical laboratory perspective","volume":"31","author":"Barr","year":"2007","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.contraception.2010.02.024_bib23","unstructured":"U.S Food and Drug Administration, Product Recalls, Hanford Pharmaceuticals [Internet site]. Rockville: United States Food and Drug Administration. Available from: http:\/\/www.fda.gov\/Safety\/Recalls\/ArchiveRecalls\/2006\/ucm111963.htm [Accessed on October 9, 2009]."},{"key":"10.1016\/j.contraception.2010.02.024_bib24","series-title":"Heparin Is Now Suspected in 62 Fatalities Across U.S","author":"Bogdanich","year":"2008"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782410000909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T23:53:45Z","timestamp":1544572425000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782410000909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0010782410000909"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2010.02.024","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}